Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
Martin
S
S
NW Regional Tissue Typing Laboratory, St Mary's Hospital, Manchester, UK.
Dyer
P A
PA
Scott
P D
PD
D000206:Actuarial Analysis; D000961:Antilymphocyte Serum / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis*; D002102:Cadaver; D016572:Cyclosporine / Q000008:administration & dosage; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis*; D007518:Isoantibodies / Q000032:analysis*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate; D014019:Tissue Donors
D000961:Antilymphocyte Serum; D001323:Autoantibodies; D006680:HLA Antigens; D007075:Immunoglobulin M; D007518:Isoantibodies; D016572:Cyclosporine